Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 5/20 | 0.47 |
| ▸ | CA2 | P00918 | 5/20 | 0.47 |
| ▸ | EEF2K | O00418 | 2/20 | 0.33 |
| ▸ | EEF2 | P13639 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | PLK4 | O00444 | 1/20 | 0.33 |
| ▸ | JAK2 | O60674 | 1/20 | 0.33 |
| ▸ | EGFR | P00533 | 1/20 | 0.33 |
| ▸ | TYK2 | P29597 | 1/20 | 0.33 |
| ▸ | FLT3 | P36888 | 1/20 | 0.33 |
| ▸ | BLM | P54132 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | ITK | Q08881 | 1/20 | 0.33 |
| ▸ | PIM2 | Q9P1W9 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21698034 | 0.79 | CA1 (0.57) | CA1CA2EEF2KEEF2MEN1 | |
| SCHEMBL21698081 | 0.78 | CA1 (0.49) | CA1CA2EEF2KEEF2MEN1 | |
| SCHEMBL21698072 | 0.76 | CA1 (0.57) | CA1CA2EEF2KEEF2MEN1 | |
| SCHEMBL27295263 | 0.76 | CA1 (0.49) | CA1CA2EEF2KEEF2MEN1 | |
| SCHEMBL21698061 | 0.74 | CA1 (0.46) | CA1CA2EEF2KEEF2MEN1 | |
| SCHEMBL27296702 | 0.73 | CA1 (0.54) | CA1CA2EEF2KEEF2MEN1 | |
| SCHEMBL27295388 | 0.72 | CA1 (0.46) | CA1CA2EEF2KEEF2MEN1 | |
| SCHEMBL21698036 | 0.72 | CA1 (0.49) | CA1CA2EEF2KEEF2MEN1 | |
| SCHEMBL27294778 | 0.70 | CA1 (0.38) | CA1CA2 | |
| SCHEMBL27297148 | 0.63 | EEF2K (0.46) | CA1CA2EEF2KEEF2MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3608312-A1 | SUBSTITUTED IMIDAZOLE SALT COMPOUNDS, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION THEREOF, AND APPLICATIONS THEREOF | Xiamen Vivohealths Technology Co., Ltd. (CN) | 2020-02-12 | — | — | EP | disclosed |